ABELLEIRA, SUSAN, M.   FOLEY HOAG LLP
107
Betreute Anmeldungen
Technische BereichePatente
Organische Feinchemie58
Pharmazeutika58
Biotechnologie18
Grundsätzliche Werkstoffchemie10
Polymerchemie3

Heimatländer der Klienten

Zusammenfassung

ABELLEIRA, Susan, M. ist besonders erfahren in den Technologien „Organische Feinchemie“ und „Pharmazeutika“. 93% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „CONCERT PHARMACEUTICALS, INC.“ und „KARYOPHARM THERAPEUTICS INC.“. Besonders viele Patentanmeldungen wurden in den Jahren 2010 und 2009 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

100
Patentanmeldungen
2
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1CONCERT PHARMACEUTICALS, INC.USA34
2KARYOPHARM THERAPEUTICS INC.USA12
3TETRAPHASE PHARMACEUTICALS, INC.USA10
4RADIUS HEALTH, INC.USA7
5ANCHOR THERAPEUTICS, INC.USA6
6DANA-FARBER CANCER INSTITUTE, INC.USA4
7METABOLIX, INC.Deutschland4
8VITAE PHARMACEUTICALS, INC.USA4
9RHYTHM METABOLIC, INC.USA3
10TENSHA THERAPEUTICS, INC.USA3
11DYNOGEN PHARMACEUTICALS, INC.Vereinigtes Königreich2
12IPSEN PHARMA S.A.S.Frankreich2
13MIMETOGEN PHARMACEUTICALS, INC.Kanada2
143M INNOVATIVE PROPERTIES COMPANY, A WHOLLY OWNED SUBSIDIARY OF 3M COMPANYUSA1
15AKRO-PLASTIC GMBHDeutschland1
16BAYLOR COLLEGE OF MEDICINEUSA1
17COLD SPRING HARBOR LABORATORYUSA1
18CONCERT PHARMACETICALS, INC.USA1
19DCAM PHARMA INCVereinigtes Königreich1
20GLAZIER, ARNOLDUSA1
21KATOLIEKE UNIVERSITEIT LEUVENUSA1
22ONCOTX, INC.USA1
23RHYTHM PHARMACEUTICALS, INC.USA1
24SHAPE PHARMACEUTICALS, INC.USA1
25THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2016210275TREATMENT OF NUT MIDLINE CARCINOMATENSHA THERAPEUTICS, INC.
2016
WO2016164810PLANTS WITH ENHANCED YIELD AND METHODS OF CONSTRUCTIONMETABOLIX, INC.
2016
WO2016100515CYCLIC COMPOUNDS AND USES THEREOFKARYOPHARM THERAPEUTICS INC.
2016
WO2016069578BROMODOMAIN INHIBITORSTENSHA THERAPEUTICS, INC.
2016
WO2016065290SEMI-SYNTHESIS PROCEDURESTETRAPHASE PHARMACEUTICALS, INC.
2016
WO2016025904POLYMORPHS OF SELINEXORKARYOPHARM THERAPEUTICS INC.
2016
WO2015149029HIGHLY FILLED POLYMER SYSTEMSMETABOLIX, INC.
2015
WO2015134567PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOFRHYTHM PHARMACEUTICALS, INC.
2015
WO2015131113TREATMENT OF CONDITIONS ASSOCIATED WITH HYPERINSULINAEMIATENSHA THERAPEUTICS, INC.
2015
WO2015095757TREATMENT OF RETINOPATHY OF PREMATURITY (ROP)THE CLEVELAND CLINIC FOUNDATION
2015
WO2015057694OPTICALLY CLEAR BIODEGRADABLE OPLYESTER BLENDSAKRO-PLASTIC GMBH
METABOLIX, INC.
2015
WO2015042414MULTICYCLIC COMPOUNDS AND METHODS OF USING SAMEKARYOPHARM THERAPEUTICS INC.
2015
WO2015010045APJ RECEPTOR COMPOUNDSANCHOR THERAPEUTICS, INC.
2015
WO2015003166SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOFKARYOPHARM THERAPEUTICS INC.
2015
WO2014210535GENETICALLY ENGINEERED METHYLOTROPHS FOR THE PRODUCTION OF PHA BIOPOLYMERS AND C3, C4, AND C5 BIOCHEMICALS FROM METHANOL OR METHANE AS SOLE CARBON FEEDSTOCKMETABOLIX, INC.
2014
WO2014205389NUCLEAR TRANSPORT MODULATORS AND USES THEREOF2014
WO2014205393NUCLEAR TRANSPORT MODULATORS AND USES THEREOFKARYOPHARM THERAPEUTICS INC.
2014
WO2014194220RECYCLATE BLENDSMETABOLIX, INC.
2014
WO2014152263EXO OLEFIN-CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOFKARYOPHARM THERAPEUTICS INC.
KATOLIEKE UNIVERSITEIT LEUVEN
2014
WO2014152275DEUTERIUM MODIFIED DERIVATIVES OF THE NS5B POLYMERASE INHIBITOR TMC647055CONCERT PHARMACEUTICALS, INC.
2014
WO2014144260PEPTIDE COMPOSITIONSRHYTHM METABOLIC, INC.
2014
WO2014144772METHODS OF PROMOTING WOUND HEALING USING CRM1 INHIBITORSKARYOPHARM THERAPEUTICS INC.
2014
WO2014144842PHARMACEUTICAL COMPOSITIONSRHYTHM METABOLIC, INC.
2014
WO2014085607SUBSTITUTED 2,3-DIHYDROBENZOFURANYL COMPOUNDS AND USES THEREOFKARYOPHARM THERAPEUTICS INC.
2014
WO2014066400METHODS FOR THE EFFECTIVE TREATMENT OF METASTATIC CANCERGLAZIER, ARNOLD
2014